Novo Holdings A/S Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001388325

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHigh Turnover how tags are computed

Q1 2024 · 35 positions · Total reported value $1.45B · Top-10 concentration 63.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 40.7% · 2 new · 8 cut · 1 exited

Active Share (vs S&P 500): 99.7% · vs QQQ: 99.3% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -12.9% · vs SPY -15.1% · Prev Value $1.72B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -0.6% · vs SPY -2.8% · Latest Value $1.49B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2024 13F filing, Novo Holdings A/S disclosed 35 equity positions with a combined reported value of $1.45B. The filing implies a focused portfolio: its ten largest positions account for 63.0% of reported value. HoldingsHub classifies the profile as Mid / Focused / High Turnover.

The largest disclosed positions as of Q1 2024 were ASML ($177.15M), BN ($162.47M), CRM ($144.61M). By sector, the heaviest allocations are Health Care 32.7%, Technology 24.5%. Versus the prior quarter, allocation shifted toward Consumer Discretionary (+8.1pp), Real Estate (+1.9pp) and away from Communication Services (-0.6pp), Technology (-0.7pp).

Versus the prior quarter, Novo Holdings A/S opened 2 new positions, trimmed 8 and fully exited 1, a turnover rate of 40.7% of positions. The portfolio's overlap with the prior quarter was 73% of names.

The largest new positions opened in Q1 2024 were EPC ($115.72M), VRDN ($19.26M), AVBP ($19.24M).

Of the 1 positions fully exited versus the prior quarter, the largest were TSM ($73.92M), EWTX ($66.42M), CBAY ($21.26M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2024)

  • EPC EDGEWELL PERSONAL CARE CO · $115.72M
  • VRDN VIRIDIAN THERAPEUTICS INC · $19.26M
  • AVBP ARRIVENT BIOPHARMA INC · $19.24M
  • MGX METAGENOMI THERAPEUTICS INC · $18.35M
  • KYTX KYVERNA THERAPEUTICS INC · $17.39M

Fully Exited (vs previous quarter)

  • TSM TAIWAN SEMICONDUCTOR MANUFAC · prev qtr: $73.92M
  • EWTX EDGEWISE THERAPEUTICS INC · prev qtr: $66.42M · history
  • CBAY CYMABAY THERAPEUTICS INC · prev qtr: $21.26M
  • SPRB SPRUCE BIOSCIENCES INC · prev qtr: $19.70M
  • RLYB RALLYBIO CORP · prev qtr: $4.23M
  • LVTX LAVA THERAPEUTICS NV · prev qtr: $2.97M

Insider Transactions (Form 4)

Latest Novo Holdings A/S buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-05-04 Conversion Hemab Therapeutics Holdings, Inc. 4,180,550 — SEC filing
2026-05-01 Buy Avalyn Pharma Inc. 555,555 $18.00 SEC filing
2026-05-01 Conversion Avalyn Pharma Inc. 3,327,734 — SEC filing

All insider transactions →

Fund Profile

Novo Holdings A/S files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 26 positions worth $1.49B in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Portfolio Structure

  • 26 positions · $1.49B reported value (Q3 2026)
  • Top 10 holdings = 76.1% of reported value
  • Largest position: EWTX (EDGEWISE THERAPEUTICS INC) at 14.6%
  • Average position size: $57.30M

Sector Tilt

  • Health Care 67.0%
  • Information Technology 17.7%
  • Real Estate 10.9%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 2 new, 6 added, 8 reduced, 1 exited
  • 10 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 32.7%
Technology 24.5%
Real Estate 13.0%
Other 12.4%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 182.54K $177.15M 12.22%
12.22%
Reduce
2 3.88M $162.47M 11.21%
11.21%
Hold
3 480.16K $144.61M 9.98%
9.98%
Reduce
4 6.34M $115.72M 7.98%
7.98%
New
5 2.41M $60.74M 4.19%
4.19%
Hold
6 845.00K $57.72M 3.98%
3.98%
Hold
7 1.10M $51.43M 3.55%
3.55%
Hold
8 118.40K $50.10M 3.46%
3.46%
Hold
9 15.81M $48.95M 3.38%
3.38%
Hold
10 1.40M $44.60M 3.08%
3.08%
Reduce
11 450.00K $39.30M 2.71%
2.71%
Hold
12 1.50M $37.68M 2.60%
2.60%
Hold
13 1.34M $36.34M 2.51%
2.51%
Hold
14 500.83K $36.24M 2.50%
2.50%
Hold
15 358.63K $34.02M 2.35%
2.35%
Hold
16 182.96K $31.37M 2.16%
2.16%
Reduce
17 2.50M $29.45M 2.03%
2.03%
Hold
18 1.05M $28.29M 1.95%
1.95%
Hold
19 1.25M $27.90M 1.93%
1.93%
Hold
20 1.17M $26.99M 1.86%
1.86%
Reduce
21 2.00M $26.56M 1.83%
1.83%
Hold
22 627.21K $26.36M 1.82%
1.82%
Hold
23 1.64M $25.69M 1.77%
1.77%
Add
24 1.10M $19.26M 1.33%
1.33%
New
25 1.08M $19.24M 1.33%
1.33%
New
26 1.74M $18.35M 1.27%
1.27%
New
27 118.38K $17.69M 1.22%
1.22%
Hold
28 700.00K $17.39M 1.20%
1.20%
New
29 65.52K $14.07M 0.97%
0.97%
Hold
30 5.09M $8.80M 0.61%
0.61%
Reduce
31 1.13M $5.10M 0.35%
0.35%
Hold
32 360.00K $4.70M 0.32%
0.32%
Hold
33 441.56K $2.63M 0.18%
0.18%
Hold
34 2.50M $1.95M 0.13%
0.13%
Hold
35 468.90K $806.51K 0.06%
0.06%
Hold

FAQ

What did Novo Holdings A/S buy in 2024-Q1?

In its 2024-Q1 13F filing, Novo Holdings A/S reported 35 equity positions worth $1.45B in aggregate; its largest disclosed positions were ASML ($177.15M), BN ($162.47M), CRM ($144.61M).

How large is Novo Holdings A/S's portfolio?

Novo Holdings A/S reported $1.45B of long equity holdings across 35 positions as of 2024-Q1. Top-10 holdings account for 63.0% of reported value.

What is Novo Holdings A/S's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/novo-holdings-a-s/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →